ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.0
  1. ホーム
  2. /反応

Diisopropylethylamine → (2-(4-(2,4-difluorophenoxy)piperidin-1-yl)-3-(isopropylamino)-7,8-dihydropyrido[3,4-b]pyrazin-6(5H)-yl)(tetrahydrofuran-2-yl)methanone

HRID 713272
ノート
印刷プレビュー

反応式

HRID 713272 の反応式
[O:1]1[CH2:5][CH2:4][CH2:3][CH:2]1[C:6]([OH:8])=O.CCN(C(C)C)C(C)C.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.OC(C(F)(F)F)=O.[F:49][C:50]1[CH:76]=[C:75]([F:77])[CH:74]=[CH:73][C:51]=1[O:52][CH:53]1[CH2:58][CH2:57][N:56]([C:59]2[N:60]=[C:61]3[CH2:72][CH2:71][NH:70][CH2:69][C:62]3=[N:63][C:64]=2[NH:65][CH:66]([CH3:68])[CH3:67])[CH2:55][CH2:54]1>CC(N(C)C)=O>[F:49][C:50]1[CH:76]=[C:75]([F:77])[CH:74]=[CH:73][C:51]=1[O:52][CH:53]1[CH2:54][CH2:55][N:56]([C:59]2[N:60]=[C:61]3[CH2:72][CH2:71][N:70]([C:6]([CH:2]4[CH2:3][CH2:4][CH2:5][O:1]4)=[O:8])[CH2:69][C:62]3=[N:63][C:64]=2[NH:65][CH:66]([CH3:68])[CH3:67])[CH2:57][CH2:58]1
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 81531DiisopropylethylamineHCID 86079(+-)-Tetrahydro-2-furoic acidHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 1317340252-(4-(2,4-difluorophenoxy)piperidin-1-yl)-N-isopropyl-5,6,7,8-tetrahydropyrido[3,4-b]pyrazin-3-amine TFA salt

生成物 1

HCID 118159231
(2-(4-(2,4-difluorophenoxy)piperidin-1-yl)-3-(isopropylamino)-7,8-dihydropyrido[3,4-b]pyrazin-6(5H)-yl)(tetrahydrofuran-2-yl)methanone

試薬・触媒・溶媒 1

HCID 31374Dimethylacetamide溶媒2 回

実験手順

To a solution of tetrahydrofuran-2-carboxylic acid (10.9 μL, 0.113 mmol) in DMA (0.35 mL) at room temperature was added DIPEA (39.5 μL, 0.226 mmol), followed by HATU (43.0 mg, 0.113 mmol). After stirring for 5 min, the reaction mixture was treated with a solution of 2-(4-(2,4-difluorophenoxyl)piperidin-1-yl)-N-isopropyl-5,6,7,8-tetrahydropyrido[3,4-b]pyrazin-3-amine TFA salt (39.0 mg, 0.075 mmol) in DMA (0.4 mL). The reaction mixture was stirred at 60° C. for 30 min. The reaction mixture was allowed to cool to room temperature and was purified directly by HPLC Method B, with the exception that a Waters SunFire™ C18, 5 μm, ID 30×75 mm column was used, using a 55% to 80% ACN gradient to give the title compound, as a TFA salt, as a yellow oil (16.0 mg, 34.5%). 1H NMR (400 MHz, methanol-d4) δ ppm 1.31 (m, 6H), 1.97 (m, 4H), 2.16 (m, 4H) 2.82 (m, 2H), 3.10 (m, 2H), 3.45 (m, 2H), 3.89 (m, 4H), 4.14 (m, 1H), 4.44-4.87 (m, 4H), 6.88 (m, 1H), 6.99 (ddd, J=11.2, 8.5, 3.0 Hz, 1H), 7.18 (td, J=9.2, 5.3 Hz, 1H); ESI-MS m/z [M+H]+ 502.6.

後処理

  1. stirringThe reaction mixture was stirred at 60° C. for 30 min
  2. customwas purified directly by HPLC Method B, with the exception that a Waters SunFire™ C18, 5 μm, ID 30×75 mm column

出典と根拠

ORDレコード
ord-0b8696f51943409d98ee30afc63aa7f8
出典データセット
uspto-grants-2015_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US09181249B2

反応ノート

読み込み中…

このページの内容参加物実験手順後処理出典と根拠反応ノート